Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Fallon Esther Chipidza, M.D.

Concepts (73)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Merkel Cell120203280.520 Why?
Diagnostic Techniques and Procedures120162160.460 Why?
Lymphoma, Non-Hodgkin1202113740.450 Why?
Mastectomy2202118480.440 Why?
Anger120164020.440 Why?
Hodgkin Disease1202113830.440 Why?
Lymphoma, Large B-Cell, Diffuse1202114330.370 Why?
Prostatic Neoplasms52023110900.300 Why?
Radiotherapy, Adjuvant3202317770.290 Why?
Zimbabwe320211350.280 Why?
Skin Neoplasms1202058360.180 Why?
Breast Neoplasms32021210690.170 Why?
Delivery of Health Care1201653640.150 Why?
Botswana1202110570.150 Why?
Prostate-Specific Antigen2202324630.140 Why?
Multiple Pulmonary Nodules120181730.130 Why?
Radiation Oncology120215680.120 Why?
Kaplan-Meier Estimate2202065030.100 Why?
Retrospective Studies82023815370.100 Why?
Data Collection1202133180.100 Why?
Aggression120167470.090 Why?
Patient Compliance1202126930.090 Why?
Neoplasm Staging32020111960.090 Why?
Cancer Care Facilities220244270.080 Why?
Tumor Suppressor Protein p531202029450.080 Why?
High-Throughput Nucleotide Sequencing1202136610.080 Why?
Proportional Hazards Models22020125290.080 Why?
Radiosurgery1201713280.070 Why?
Carcinoma, Pancreatic Ductal1201817590.070 Why?
Tumor Microenvironment1202039400.070 Why?
Drug Prescriptions1201616620.070 Why?
Mutation22021301920.070 Why?
Prognosis32022298900.060 Why?
Humans1620247659260.060 Why?
Gene Expression Regulation, Neoplastic1202186030.060 Why?
Prostate2202317580.060 Why?
Neoplasms22024223400.060 Why?
Adjuvants, Pharmaceutic12023480.060 Why?
Lung Neoplasms22018134460.050 Why?
Physician-Patient Relations1201632700.050 Why?
Neoadjuvant Therapy2202328950.040 Why?
Pancreatic Neoplasms1201854500.040 Why?
Analgesics, Opioid1201638340.040 Why?
Health Services Misuse120212450.040 Why?
Carcinoma, Non-Small-Cell Lung1201753790.040 Why?
Salvage Therapy1202312720.030 Why?
Male820233638150.030 Why?
Survival Rate22021128220.030 Why?
Prostatectomy1202317860.030 Why?
SEER Program1202014430.030 Why?
Risk Assessment12016242750.030 Why?
Needs Assessment1202011400.030 Why?
Treatment Outcome12020651940.030 Why?
DNA Repair1202220480.030 Why?
Female520213961410.020 Why?
Artificial Intelligence1202426610.020 Why?
Middle Aged520212230160.020 Why?
Healthcare Disparities1202434070.020 Why?
Risk1202095990.020 Why?
Aged420201711630.020 Why?
Palliative Care1202136400.020 Why?
Neoplasm Recurrence, Local1202393730.020 Why?
Clinical Trials as Topic1202080370.010 Why?
Age Factors12020183820.010 Why?
Health Services Accessibility1202155090.010 Why?
Incidence12020215130.010 Why?
Follow-Up Studies12021392280.010 Why?
Case-Control Studies12017222280.010 Why?
Cohort Studies12020416800.010 Why?
Tomography, X-Ray Computed12018206900.010 Why?
Adult220212230880.010 Why?
Risk Factors12021748500.010 Why?
United States12020729090.010 Why?
Chipidza's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (73)
Explore
_
Co-Authors (53)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.